About Amvissa Pharmaceuticals
Amvissa Pharmaceuticals was a Healthcare company based in Delhi (India) founded in 2012. It produces high-quality finished pharmaceutical formulations. It operates on a B2B model. Its Indian entity Amvissa Pharmaceuticals Private Limited reported revenue of ₹5 Lakh. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Manufacturing and Finished Formulations. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Amvissa Pharmaceuticals produces high-quality finished pharmaceutical formulations through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and finished formulations. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Delhi, India
- SectorsHealthcare
- Website amvissa.com
- Legal Name Amvissa Pharmaceuticals Private Limited
- Date of Incorporation 04 Jan, 2012
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹5 Lakh
FY 2017
- Net Loss-₹1.7 Lakh
FY 2017 · -34% margin
- EBITDA-₹1.6 Lakh
FY 2017 · -32% margin
Associated legal entities of Amvissa Pharmaceuticals
Amvissa Pharmaceuticals operates through Amvissa Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2017) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Amvissa Pharmaceuticals Private Limited CIN U24232DL2012PTC229641 | Active | 04 Jan 2012 | New Delhi, Delhi | ₹0.1 Cr | 2 | View details |
Board of directors of Amvissa Pharmaceuticals Private Limited (Amvissa Pharmaceuticals)
Amvissa Pharmaceuticals Private Limited is the primary company behind Amvissa Pharmaceuticals. The board of Amvissa Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Veena Kumari, appointed in 2012.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Veena Kumari DIN 05148841 | Director | 04 Jan 2012 | 14 yrs 9 mo | Amvissa Pharmaceuticals Private Limited |
| Vinay Krishna DIN 05148849 | Director | 04 Jan 2012 | 14 yrs 9 mo | Amvissa Pharmaceuticals Private Limited |
Financials of Amvissa Pharmaceuticals
Figures of Amvissa Pharmaceuticals Private Limited, the primary company behind Amvissa Pharmaceuticals, for FY 2017. Revenue was ₹5 Lakh. Net loss was -₹1.7 Lakh (-34% margin). EBITDA was -₹1.6 Lakh (-32% margin).
- ₹5 LakhRevenue · FY 2017
- -₹1.7 LakhNet loss · -34% margin
- -₹1.6 LakhEBITDA · -32% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Amvissa Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Amvissa Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Amvissa Pharmaceuticals
Amvissa Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Amvissa Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Amvissa Pharmaceuticals
Amvissa Pharmaceuticals was founded in 2012.
Amvissa Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Amvissa Pharmaceuticals, Amvissa Pharmaceuticals Private Limited, reported revenue of ₹5 Lakh for FY 2017.
Amvissa Pharmaceuticals produces high-quality finished pharmaceutical formulations through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and finished formulations. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Amvissa Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Amvissa Pharmaceuticals operates through Amvissa Pharmaceuticals Private Limited.
The legal entities of Amvissa Pharmaceuticals currently have 2 directors, including Veena Kumari, Vinay Krishna.